Drugmaker Hikma ' s U.S. Unit Raises Medicine Prices -Financial Times Drugmaker Hikma ' s U.S. Unit Raises Medicine Prices -Financial Times

Hikma Pharmaceuticals Plc ' s U.S. subsidiary has raised the price of a common diarrhea drug by more than 400% and is charging more for five other medicines as well, the Financial Times reported on Sunday.Reuters Health Information

Source: Medscape Today Headlines - August 22, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news